A Phase II Study in Patients With Alopecia Areata

Completed · Phase 2 · Has a placebo group

Conditions studied: Alopecia Areata

In brief

This is a global Phase 2 study to evaluate the safety and effectiveness of an investigational study drug (called SHR0302) in adults with moderate to severe alopecia areata.

Key facts

Study ID

NCT04346316

Run by

Reistone Biopharma Company Limited

People needed

94

Starts

2020-05-13

Expected to finish

2021-06-29

Last updated by the study team

2021-07-16

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female subjects between 18-65 years of age (both inclusive), at the time of informed consent;
• Must have moderate to severe alopecia areata.

You may not qualify if…

• Other types of alopecia or other diseases that can cause hair loss
• Other scalp diseases that could interfere with assessment of hair loss/regrowth
• Any previous use of any Janus kinase (JAK) inhibitor

Where it is running

• Quest Dermatology Research — Northridge, California, United States
• Moore Clinical Research — Brandon, Florida, United States
• Dawes Fretzin Clinical Research — Indianapolis, Indiana, United States
• Skin Search of Rochester, Inc — Rochester, New York, United States
• Dermatologists of Southwest Ohio — Mason, Ohio, United States
• The Skin Wellness Center — Knoxville, Tennessee, United States
• Progressive Clinical Research — San Antonio, Texas, United States
• St George Dermatology and Skin Cancer Centre — Kogarah, New South Wales, Australia
• Novatrials — Kogarah, New South Wales, Australia
• Veracity Clinical Research — Woolloongabba, Queensland, Australia
• Skin Health Institute — Carlton, Victoria, Australia
• Sinclair Dermatology — East Melbourne, Victoria, Australia
• Sinclair Dermatology — Melbourne, Victoria, Australia
• China-Japan Friendship Hospital — Beijing, Beijing Municipality, China
• Peking University First Hospital — Beijing, Beijing Municipality, China
• Peking University People's Hospital — Beijing, Beijing Municipality, China
• Beijing Friendship Hospital, Capital Medical University — Beijing, Beijing Municipality, China
• Beijing Tongren Hospital, Capital Medical University — Beijing, Beijing Municipality, China
• Beijing Friendship Hospital, Capital Medical University — Beijing, Beijing Municipality, China
• Beijing Tongren Hospital, Capital Medical University — Beijing, Beijing Municipality, China
• Peking University People's Hospital — Beijing, Beijing Municipality, China
• Chongqing Traditional Chinese medicine Hospital — Chongqing, Chongqing Municipality, China
• The First Affiliated Hospital of Chongqing Medical University — Chongqing, Chongqing Municipality, China
• The First Affiliated Hospital of Fujian Medical University — Fuzhou, Fujian, China
• Guangdong Provincial People's Hospital — Guangzhou, Guangdong, China

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.